Meeting
2013 ASCO Annual Meeting
Analysis of health-related quality of life during neoadjuvant endocrine therapy with letrozole in postmenopausal breast cancer patients: N-SAS BC06 trial.
Authors
Shoichiro Ohtani
Hiroshima City Hospital, Hiroshima, Japan
Shoichiro Ohtani , Naruto Taira , Kiyohiro Kihara , Yoshie Hasegawa , Takehiko Sakai , Takuji Iwase , Norikazu Masuda , Tomomi Fujisawa , Yasuhiro Yanagita , Shozo Ohsumi , Kenji Higaki , Takuhiro Yamaguchi , Hiroji Iwata
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Health Services Research
Track
Health Services Research
Sub Track
Outcomes and Quality of Care
Clinical Trial Registration Number
000001090
Citation
J Clin Oncol 31, 2013 (suppl; abstr 6588)
DOI
10.1200/jco.2013.31.15_suppl.6588
Abstract #
6588
Poster Bd #
17D
Abstract Disclosures
Similar Posters
Poster
2020 ASCO Virtual Scientific Program
CIFeR: A novel Clinician-lead Intervention to address Fear of cancer Recurrence (FCR) in breast cancer survivors.
First Author: Jia Liu
Poster
2023 ASCO Breakthrough
Delayed versus immediate use of zoledronic acid for postmenopausal patients with ER/PR positive early breast cancer who are using adjuvant letrozole.
First Author: Mai Abdel Gelil
Poster
2023 ASCO Annual Meeting
Association of emotional support with quality of life, mental health, and survival among older adults with gastrointestinal (GI) malignancies.
First Author: Daniel Clausing
Poster
2022 ASCO Annual Meeting
AMEERA-4: A preoperative window-of-opportunity (WOO) study to assess the pharmacodynamic (PD) activity of amcenestrant or letrozole in postmenopausal patients with ER+/HER2− primary breast cancer.
First Author: Mario Campone